The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.

Gladstone Foundation Board of Directors

Bill Younger

Chairman
William H. Younger, Jr.
Managing Director, Sutter Hill Ventures

Stasia Obremskey

Vice Chair
Stasia A. Obremskey
Strategy Director, Contraceptive Technology Development, Rhia Ventures 

Board Members

Chris Boskin
Media Consultant

Marianne De Backer, PhD, MBA
Head of Pharmaceuticals Business Development and Licensing, Bayer

Paul C. Edwards
Edwards Partners

Tom Furst
Former CFO, SRI International

Linda Grais, MD, JD
Former President and CEO, Ocera Therapeutics

Erin Hoffmann
President and Co-Founder at Additional Ventures

Perry Karsen
Former CEO, Celgene Cellular Therapeutics and EVP, Chief Operations Officer of Celgene Corporation

Laura S. Lehman, PhD
Vice President, Research Strategy and Portfolio Management, Gilead Sciences

Gary Morgenthaler
Partner, Morgenthaler Ventures

Steve Richardson
CEO, Alexandria Real Estate

Douglas G. Scrivner
Retired General Counsel, Accenture

Deepak Srivastava, MD
President, Gladstone Institutes
Director, Roddenberry Stem Cell Center

Gary T. Steele
Retired Chairman, President, and CEO, Landec

James B. Tananbaum, MD
Founder, CEO, and Managing Director, Foresite Capital Management

R. Sanders Williams, MD
President Emeritus, Gladstone Institutes

Sharon Winslow
Attorney

Board Officers

Chris Nicholson
Secretary

Michelle Sibly
Treasurer

Robert Wicks
CEO